Goldmann's equation and clinical measures of aqueous dynamics

Experimental Eye Research

Volumn 78, Issue 3, 2004, Pages 633-637

  Brubaker, Richard F ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Goldmann's equation; Tonometer; Uveo scleral pathway

Indexed keywords

AQUEOUS HUMOR; AQUEOUS HUMOR FLOW; CALCULATION; FLUOROPHOTOMETRY; GLAUCOMA; HUMAN; PRIORITY JOURNAL; REVIEW; STEADY STATE; TONOMETRY;

EID: 0842309567     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.07.002     Document Type: Article

References (34)

1. Alm A., Villumsen J. PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol. 109:1991;1564-1568.
2. Ascher K.W. Aqueous veins. Am. J. Ophthalmol. 25:1942;31-38.
3. Bárány E.H. A mathematical formulation of intraocular pressure as dependent on secretion, ultrafiltration, bulk outflow, and osmotic reabsorption of fluid. Invest. Ophthalmol. 2:1963;584-590.
4. Becker B., Neufeld A.H. Pressure dependence of uveoscleral outflow. J. Glaucoma. 11:2002;464.
5. Bill A. The aqueous humor drainage mechanism in the cynomolgus monkey (Macaca irus) with evidence for unconventional routes. Invest. Ophthalmol. 4:1965;911-919.
6. Bill A. Conventional and uveo-scleral drainage of aqueous humour in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp. Eye Res. 5:1966;45-54.
7. Bill A. Some thoughts on the pressure dependence of uveoscleral flow. J. Glaucoma. 12:2003;88-89.
8. Bill A., Phillips C.I. Uveoscleral drainage of aqueous humor in human eyes. Exp. Eye Res. 12:1971;275-281.
9. Brubaker R. Mechanism of action of bimatoprost (Lumigan). Surv. Ophthalmol. 45:2001;S347-S351.
10. Brubaker R.F., Johnson S.A., Beeler G.W. The stress-strain behavior of the corneoscleral envelope of the eye II. In vivo measurements in Rhesus monkey eyes. Exp. Eye Res. 24:1977;425-435.
11. Brubaker R.F., Schoff E.O., Nau C.B., Carpenter S.P., Chen K., VanDenburgh A.M. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am. J. Ophthalmol. 131:2001;19-24.
12. Camras C.B. Some thoughts on the pressure dependence of uveoscleral flow. J. Glaucoma. 12:2003;92-93.
13. Gabelt B.T., Kaufman P.L. Prostaglandin F2a increases uveoscleral outflow in the cynomolgus monkey. Exp. Eye Res. 49:1989;389-402.
14. Goldmann H.A. Minute Volume und Widerstand der Kammerwasserstromung des Menschen. Doc. Ophthalmol. 5-6:1951;278-356.
15. Grant W.M. Tonographic method for measuring the facility and rate of aqueous flow in human eyes. Arch. Ophthalmol. 44:1950;204-214.
16. Grant W.M., Trotter R.R. Diamox (acetazolamide) in treatment of glaucoma. Arch. Ophthalmol. 51:1954;735-739.
17. Hayashi M., Yablonski M.E., Bito L.Z. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins. Invest. Ophthalmol. Vis. Sci. 28:1987;1639-1643.
18. Hayashi M., Yablonski M.E., Novack G.D. Trabecular outflow facility determined by fluorophotometry in human subjects. Exp. Eye Res. 48:1989;621-625.
19. Holm O. A photogrammetric method for estimation of the pupillary aqueous flow in the living eye. Acta Ophthalmol. (Copenh.). 46:1968;254-277.
20. Jones R.F., Maurice D.M. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp. Eye Res. 5:1966;208-220.
21. Kaufman P.L. Some thoughts on the pressure dependence of uveoscleral flow. J. Glaucoma. 12:2003;89.
22. Kaufman P.L., Bárány E.H. Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest. Ophthalmol. 15:1976;793-807.
23. Langham M.E., Leydhecker W., Krieglstein G., Waller W. Pneumatonographic studies on normal and glaucomatous eyes. Adv. Ophthalmol. 32:1976;108-133.
24. Lee D.A., Topper J.E., Brubaker R.F. Effect of clonidine on aqueous humor flow in normal human eyes. Exp. Eye Res. 38:1984;239-246.
25. Maklakoff. Arch. Ophthal. (Paris). 5:1885;159-165.
26. Maurice D.M. A new objective fluorophotometer. Exp. Eye Res. 2:1963;33-38.
27. Mishima H.K., Kiuchi Y., Takamatsu M., et al. Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow. Surv. Ophthalmol. 41:1997;S139-S144.
28. O'Rourke J., Macri F.J. Studies in uveal physiology: II. Clinical studies of the anterior chamber clearance of isotopic tracers. Arch. Ophthalmol. 84:1970;415-420.
29. Schachtschabel U., Lindsey J.D., Weinreb R.N. The mechanism of action of prostaglandins on uveoscleral outflow. Curr. Opin. Ophthalmol. 11:2000;112-115.
30. Toris C.B., Camras C.B., Yablonski M.E. Effects of PhXA41, a new prostaglandin F2a analogue, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
31. Toris C.B., Camras C.B., Yablonski M.E., Brubaker R.F. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv. Ophthalmol. 23:1997;S69-S75.
32. Yablonski M.E. Some thoughts on the pressure dependence of uveoscleral flow. J. Glaucoma. 12:2003;90-91.
33. Yablonski M.E., Zimmerman T.J., Waltman S.R., Becker B. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp. Eye Res. 27:1978;135-142.
34. Ziai N., Dolan J.W., Kacere R.D., Brubaker R.F. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Arch. Ophthalmol. 111:1993;1351-1358.